A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal
Titel:
A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal
Auteur:
Yu, Elmer Miotto, Karen Akerele, Evaristo Montgomery, Ann Elkashef, Ahmed Walsh, Robert Montoya, Ivan Fischman, Marian W. Collins, Joseph McSherry, Frances Boardman, Kathy Davies, David K. O’Brien, Charles P. Ling, Walter Kleber, Herbert Herman, Barbara H.